Role of nitric oxide in the regulation of oxygen consumption in conscious dogs

Circulation Research

Volumn 75, Issue 6, 1994, Pages 1086-1095

  Shen, Weiqun ^a   Xu, Xiaobin ^a   Ochoa, Manuel ^a   Zhao, Gong ^a   Wolin, Michael S ^a   Hintze, Thomas H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

barbiturates; cardiac output; constitutive nitric oxide synthase; mitochondrial function; nitro L arginine; oxygen extraction

Indexed keywords

ATROPINE; HEMOGLOBIN; HEXAMETHONIUM; METHOXAMINE; N(G) NITROARGININE; NITRIC OXIDE; OXYGEN; OXYHEMOGLOBIN; PENTOBARBITAL;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DOG; HEART OUTPUT; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN SATURATION; OXYGEN TENSION; PRIORITY JOURNAL; VASCULAR RESISTANCE;

EID: 0028061310     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.75.6.1086     Document Type: Article

References (39)

1. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988;153:1251-1256.
2. Schmidt HHHW, Nau H, Wittfoht W, Gerlach J, Prescher KE, Klein MM, Niroomand F, Bohme E. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol. 1988;154:213-216.
3. Moncada S, Higgs EA, Hodson HF, Knowles RG, Lopez-Jaramillo P, McCall T, Palmer RMJ, Radomski MW, Rees DD, Schulz R. The L-arginine:nitric oxide pathway. J Cardiovasc Pharmacol. 1991; 17(suppl 3):S1-S9.
4. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
5. Ignarro LJ, Bug GM, Wood KS, Byrns RE. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84:9265-9269.
6. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991;351:714-718.
7. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988;157:87-94.
8. Marletta MA, Toon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 1988;27:8706-8711.
9. Drapier SC, Hibbs JB. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol. 1988;140:2829-2838.
10. Drapier SR, Hibbs JB. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. J Clin Invest. 1986;78:790-797.
11. Granger DL, Lehninger AL. Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J Cell Biol. 1982;95:527-535.
12. Stadler J, Curran RD, Ochoa JB, Harbrecht BG, Hoffman RA, Simmons RL, Billiar TR. Effect of endogenous nitric oxide on mitochondrial respiration of rat hepatocytes in vitro and in vivo. Arch Surg. 1991;126:186-191.
13. Stadler J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB, Simmons RL. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol. 1991;260: C910-C916.
14. Geng YJ, Hansson GK, Holme E. Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res. 1992;71:1268-1276.
15. Shen W, Wang J, Xu X, Hintze TH. EDRF-mediated coronary dilation following carotid chemoreflex stimulation in conscious dogs. FASEB J. 1993;7:A213. Abstract.
16. King BD, Sack D, Kichuk MR, Hintze TH. Absence of hypertension despite chronic marked elevations in plasma norepinephrine in conscious dogs: role of neural mechanisms. Hypertension. 1987;9:143-151.
17. G-nitro-L-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothelium-derived relaxing factor release in the isolated rabbit heart. Eur J Physiol. 1991;418:266-270.
18. G-nitro arginine (L-NOARG), a novel L-arginine reversible inhibitor of endothelium-dependent vasodilation in vitro. Br J Pharmacol. 1990;99:408-412.
19. 5-[imino(nitroamino) methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn Schmiedebergs Arch Pharmacol. 1990;341:143-147.
20. Hintze TH, Shen W, Wang J, Lundborg M. Role of EDRF/shear rate in the control of blood flow during exercise. J Am Coll Cardiol. 1993;21:432A. Abstract.
21. Shen W, Lundborg M, Wang J, Xu X, Hintze TH. An endothelium-derived relaxing factor mediated mechanism buffers renal and splanchnic vasoconstriction during acute exercise in conscious dogs. Circulation. 1993;88(suppl I):I-376. Abstract.
22. Wang J, Wolin MS, Hintze TH. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res. 1993;73:829-838.
23. Elsner D, Muntze A, Kromer EP, Reigger GAA. Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure. Cardiovasc Res. 1991;25:438-440.
24. Wharton M, Granger DL, Durack DT. Mitochondrial iron loss from leukemia cells injured by macrophages: a possible mechanism for electron transport chain defects. J Immunol. 1988;141: 1311-1317.
25. Reif DW, Simmons RD. Nitric oxide mediates iron release from ferritin. Arch Biochem Biophys. 1990;283:537-541.
26. Lancaster JR Jr, Hibbs JB. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci U S A. 1990;87:1223-1227.
27. Stuehr DJ, Cho HJ, Kown NS, Weise MF, Nathan CF. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci U S A. 1991;88:7773-7777.
28. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 1994;74:349-353.
29. Wang J, Kobari Y, Lin J, Pritchard KA, Wolin MS, Hintze TH. Mechanism of defective conversion of arachidonic acid to prosta-glandins during heart failure. Circulation. 1993;88(suppl I):I-567. Abstract.
30. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43: 109-142.
31. Busch C, Cancilla PA, DeBault LE, Goldsmith JC, Owen WG. Methods in laboratory investigation: use of endothelium cultured on microcarriers as a model for the microcirculation. Lab Invest. 1982;47:498-504.
32. Heyndrickx GR, Boettcher DH, Vatner SF. Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol. 1976;231:1579-1587.
33. Hoffbrand BI, Forsyth RP. Regional blood flow changes during norepinephrine, tyramine and methoxamine infusions in the unanesthetized rhesus monkey. J Pharmacol Exp Ther. 1973;184: 656-661.
34. G-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo: a role for nitric oxide in the central regulation of sympathetic tone? Circ Res. 1992;70:607-611.
35. Harada S, Tokunaga S, Momohara M, Masaki H, Tagawa T, Imaizumi T, Takeshita A. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res. 1993;72:511-516.
36. Palmer G, Horgan DJ, Tisdale H, Singer TP, Beinert H. Studies on the respiratory china-linked reduced nicotinamide adenine dinucleotide dehydrogenase, XIV: location of the sites of inhibition of rotenone, barbiturates, and piericidin by means of electron paramagnetic resonance spectroscopy. J Biol Chem. 1968;243:844-847.
37. Hatefi Y. Flavoproteins of the electron transport system and the site of action of amytal, rotenone, and piericidin A. Proc Natl Acad Sci U S A. 1968;60:733-740.
38. King CE, Melinshyn MJ, Mewburn JD, Curtis SE, Winn ME, Cain SM, Chapler CK. Canine hindlimb blood flow and oxygen uptake after inhibition of EDRF/NO synthesis. J Appl Physiol. 1994;76: 1166-1171.
39. Buxton IL, Cheek DL, Eckman D, Westfall DP, Sanders KM, Keef KD. N-Nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res. 1993;72: 387-395.